Feature
Article
Pharmaceutical Executive
2025 Emerging Pharma Leaders
Author(s):
Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives steering innovative scientific and strategic pursuits in R&D, market access, and patient support.
Follow the links below to read about each selection:
(In alphabetical order)
Bryan Mazlish, Co-founder and CEO, Surf Bio
Samir Ounzain, Co-founder and CEO, HAYA Therapeutics
Bill Rush, Head of US Market Access Portfolio Management, Sanofi
Janine Sengstack, PhD, Co-founder and Chief Scientific Officer, Junevity
Amy Simon, MD, Chief Medical Officer, Beam Therapeutics
*These five individuals were chosen from a pool of nominations by the Pharmaceutical Executive Editorial staff. Selections were based on a number of criteria and review of professional accomplishments and progression of responsibilities in line with those executives inhabiting key “c-suite” functions.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
